Discover our latest insights. 

Advancements in cancer care over the past 20 years have been transformational, driven by updated recommendations in cancer screening, emergence of molecular diagnostic tools to guide treatments, and the development of cutting-edge therapeutics. Each offers the potential for better outcomes, but employers are faced with the challenge of ensuring these often costly tools and treatments are used effectively.

In the newly published whitepaper, "Managing Cancer Care in Your Health Plan," Private Health Management (PHM) and Springbuk experts provide insights for employers to improve cancer outcomes and optimize cancer spend. Download the whitepaper now.

PHM is pleased to be a contributing partner to Springbuk’s 2023 Employee Health Trends report. The newly released report provides recommendations that will impact how benefits leaders plan, deliver, and evaluate employee benefits programs.

1. Effects of COVID-19 on costs and health
2. Surges in cancer costs
3. Specialty drug use
4. Telemedicine & mental health services

Dr. Natalya Gertsik, PHM’s Vice President, ClearCancer Solution Management, offers key insights on earlier cancer detection, improving outcomes, and reducing cancer-related spending.

Private Health researchers and clinicians recently published a case study in the journal Clinical Colorectal Cancer, highlighting the importance of molecular profiling to identify precision, life-changing medicines to patients.

Read our scientific findings from our team of researchers and clinicians recently published in Clinical Colorectal Cancer highlighting the importance of molecular profiling to provide precision, life-changing medicine to patients.